Heterogeneity of Toll-Like Receptor 9 Signaling in B Cell Malignancies and Its Potential Therapeutic Application

Journal of Translational Medicine - United Kingdom
doi 10.1186/s12967-017-1152-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

TGFβ Activated Kinase 1 (TAK1) at the Crossroad of B Cell Receptor and Toll-Like Receptor 9 Signaling Pathways in Human B Cells

PLoS ONE
Multidisciplinary
2014English

Bifurcation of Toll-Like Receptor 9 Signaling by Adaptor Protein 3

Science
MultidisciplinaryPhilosophy of ScienceHistory
2010English

Toll-Like Receptor 2 Signaling and Current Approaches for Therapeutic Modulation in Synucleinopathies

Frontiers in Pharmacology
Pharmacology
2018English

Regulation of Migration and Invasion by Toll-Like Receptor-9 Signaling Network in Prostate Cancer

Oncotarget
Oncology
2015English

Toll-Like Receptor-9 Is Involved in the Development of B Cell Stimulating Factor-Induced Systemic Lupus Erythematosus

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

Porcine B Cell Subset Responses to Toll-Like Receptor Ligands

Frontiers in Immunology
AllergyImmunology
2017English

Targeting of B-Cell Receptor Signalling in B-Cell Malignancies

Journal of Internal Medicine
Internal Medicine
2017English

Toll Like Receptor-9 Mediated Invasion in Breast Cancer

2012English

Toll Like Receptor-9 Mediated Invasion in Breast Cancer

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy